ArticleBritish journal of cancer2008

Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study.

L Mellemkjaer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.